Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for PSNL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 76.97M
March 31, 2026 70.63M
December 31, 2025 72.98M
September 30, 2025 71.42M
June 30, 2025 67.85M
March 31, 2025 65.96M
December 31, 2024 67.31M
September 30, 2024 73.13M
June 30, 2024 73.23M
March 31, 2024 74.58M
December 31, 2023 95.66M
September 30, 2023 75.43M
June 30, 2023 72.95M
March 31, 2023 78.55M
December 31, 2022 74.56M
September 30, 2022 75.46M
Date Value
June 30, 2022 93.35M
March 31, 2022 93.93M
December 31, 2021 86.23M
September 30, 2021 81.40M
June 30, 2021 44.59M
March 31, 2021 47.09M
December 31, 2020 49.90M
September 30, 2020 45.27M
June 30, 2020 52.40M
March 31, 2020 52.68M
December 31, 2019 50.60M
September 30, 2019 48.30M
June 30, 2019 74.83M
March 31, 2019 78.77M
December 31, 2018 58.65M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Tempus AI, Inc. 1.921B
10X Genomics, Inc. 204.52M
Alamar Biosciences, Inc. (California) 78.12M
Adaptive Biotechnologies Corp. 490.02M
Champions Oncology, Inc. 22.92M

Total Liabilities (Quarterly) Related Metrics